Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 9

Results For "import"

2289 News Found

Vision 360 brings academia, industry together to advance ophthalmic therapies
Healthcare | April 25, 2026

Vision 360 brings academia, industry together to advance ophthalmic therapies

VESCOP, ENTOD Pharmaceuticals, and APTI-MSB host the event to bridge lab-to-clinic gap in eye care


Nihilent launches nSEPIA Beta, introduces AI-driven emotional wellness platform
Digitisation | April 25, 2026

Nihilent launches nSEPIA Beta, introduces AI-driven emotional wellness platform

AI-powered platform uses real-time emotion scanning and personalised interventions to make emotional wellness measurable and actionable


India Autism Center hosts ‘Sports for All’ initiative to advance inclusive sporting ecosystem
Public Health | April 25, 2026

India Autism Center hosts ‘Sports for All’ initiative to advance inclusive sporting ecosystem

Multi-stakeholder initiative highlights inclusive sports pathways, honours neurodivergent athletes, and calls for systemic reforms


Bayer’s comeback gains speed as CEO warns: “The Work Isn’t Complete. Yet
News | April 25, 2026

Bayer’s comeback gains speed as CEO warns: “The Work Isn’t Complete. Yet"

The Pharmaceuticals portfolio and pipeline are more promising than perhaps ever before


Siegfried locks in major CDMO expansion deal as US & Australia sites join global network from May 1
News | April 25, 2026

Siegfried locks in major CDMO expansion deal as US & Australia sites join global network from May 1

The acquisition brings three established small-molecule drug substance facilities into Siegfried’s global network


New genomics clinic by Fortis Hospitals targets early disease detection
Healthcare | April 24, 2026

New genomics clinic by Fortis Hospitals targets early disease detection

New facility offers genetic testing, counselling and personalised treatment plans to enable early diagnosis and precision-led care


Biocon receives Health Canada approval for Bosaya and Vevzuo biosimilars to Prolia and Xgeva
Biopharma | April 24, 2026

Biocon receives Health Canada approval for Bosaya and Vevzuo biosimilars to Prolia and Xgeva

Denosumab biosimilars approved in Canada to expand access for osteoporosis and cancer-related bone conditions


AbbVie bets $1.4B on North Carolina pharma mega-campus
News | April 23, 2026

AbbVie bets $1.4B on North Carolina pharma mega-campus

Once complete, the site will serve as AbbVie’s U.S. center of excellence for SVP manufacturing


Cipla’s generic Ventolin HFA secures USFDA approval
Drug Approval | April 23, 2026

Cipla’s generic Ventolin HFA secures USFDA approval

Approval for Albuterol Sulfate inhalation aerosol enables Cipla Limited to enter the $1.5 billion U.S. albuterol market


Vice-President calls for integrity in medical practice at AIIMS Rishikesh convocation
Hospitals | April 23, 2026

Vice-President calls for integrity in medical practice at AIIMS Rishikesh convocation

C. P. Radhakrishnan urged graduates to uphold ethical standards and maintain a commitment to patient care